4.1 Article

LINE-1 methylation is inherited in familial testicular cancer kindreds

期刊

BMC MEDICAL GENETICS
卷 11, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/1471-2350-11-77

关键词

-

资金

  1. Intramural Research Program of the NIH
  2. National Cancer Institute
  3. Division of Cancer Epidemiology and Genetics
  4. Westat Inc [NO2-CP-11019-50, NO2-CP-65504-50]

向作者/读者索取更多资源

Background: Testicular germ cell tumors (TGCT) are the most frequent cancers among young men. There is a clear familial component to TGCT etiology, but no high-penetrance susceptibility gene has been identified. Epigenetic aberrations of the genome represent an alternative mechanism for cancer susceptibility; and, studies suggest that epigenetic changes that influence cancer risk can be inherited through the germline. Global DNA hypomethylation has been associated with the risk of cancers of the bladder and head/neck. Methods: We performed a pilot study of global methylation at long interspersed nuclear elements-1 (LINE-1) in peripheral blood DNA isolated from 466 family members of 101 multiple-case testicular cancer families. Results: Investigating the correlation of LINE-1 methylation levels among parent-child pairs independent of affection status (n = 355) revealed a strong positive association only between mother-daughter (r = 0.48, P = <0.001) and father-daughter pairs (r = 0.31, P = 0.02), suggesting gender-specific inheritance of methylation. Incorporating cancer status, we observed a strong correlation in LINE-1 methylation levels only among affected father-affected son pairs (r = 0.49, P = 0.03). There was a marginally significant inverse association between lower LINE-1 methylation levels and increased TGCT risk, compared with healthy male relatives (P = 0.049). Conclusions: Our data suggest that heritability of LINE-1 methylation may be gender-specific. Further, the strong correlation between LINE-1 methylation levels among affected father-affected son pairs suggests that transgenerational inheritance of an epigenetic event may be associated with disease risk. Larger studies are needed to clarify these preliminary observations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Utility of interim blood tests for cancer screening in Li-Fraumeni syndrome

Leatrisse Oba, Ana F. Best, Phuong L. Mai, Maria Isabel Achatz, Paul S. Albert, Sharon A. Savage, Payal P. Khincha

Summary: Intermediate 4- and 8-monthly screening blood tests may not provide independent benefit for early cancer detection in Li-Fraumeni syndrome (LFS) patients, but annual comprehensive screening and personalized follow-up remain essential.

FAMILIAL CANCER (2022)

Article Hematology

Disease progression and clinical outcomes in telomere biology disorders

Marena R. Niewisch, Neelam Giri, Lisa J. McReynolds, Rotana Alsaggaf, Sonia Bhala, Blanche P. Alter, Sharon A. Savage

Summary: This study examined the associations between mode of inheritance in Dyskeratosis congenita related telomere biology disorders (DC/TBDs) and the clinical manifestations and long-term outcomes. The results showed that different modes of inheritance were correlated with different clinical presentations, and they also had an impact on the survival of patients.
Editorial Material Hematology

Telomere biology disorders gain a family member Comment

Sharon A. Savage

Summary: In this study, novel pathogenic variants in RPA1 were discovered as a new cause of TBDs. The researchers investigated the clinical manifestations in patients from different families, and revealed the role of RPA1 in hematopoiesis and telomeric DNA binding and unfolding. The discovery enhances our understanding of RPA function in telomere biology and provides valuable information for families in understanding the cause of their illness.
Letter Dermatology

Spectrum and Incidence of Skin Cancer among Individuals with Li-Fraumeni Syndrome

Jessica N. Hatton, Michael R. Sargen, Megan N. Frone, Kelvin C. de Andrade, Sharon A. Savage, Payal P. Khincha

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Medicine, General & Internal

Lipoprotein particle alterations due to androgen therapy in individuals with dyskeratosis congenita

Mone't B. Thompson, Daniel Muldoon, Kelvin C. de Andrade, Neelam Giri, Blanche P. Alter, Sharon A. Savage, Robert D. Shamburek, Payal P. Khincha

Summary: The study found that oral androgen therapy in DC patients altered lipid and lipoprotein levels, potentially increasing the risk of atherogenic cardiovascular disease. Individuals on androgens for DC-related BMF should undergo cardiovascular disease monitoring.

EBIOMEDICINE (2022)

Letter Hematology

A core group of structurally similar HLA-DPB1 alleles drives permissiveness after hematopoietic cell transplantation

Esteban Arrieta-Bolanos, Pietro Crivello, Meilun He, Tao Wang, Shahinaz M. Gadalla, Sophie Paczesny, Steven G. E. Marsh, Stephanie J. Lee, Stephen R. Spellman, Yung-Tsi Bolon, Katharina Fleischhauer

Letter Oncology

Pilot study of the prevalence of autoimmune disorders in Li-Fraumeni syndrome

Ixtaccihuatl H. Obregon, Kelvin C. de Andrade, Renee C. Bremer, Payal P. Khincha, Sharon A. Savage

FAMILIAL CANCER (2023)

Article Oncology

Impact of the HLA Immunopeptidome on Survival of Leukemia Patients After Unrelated Donor Transplantation

Pietro Crivello, Esteban Arrieta-Bolanos, Meilun He, Tao Wang, Stephanie Fingerson, Shahinaz M. Gadalla, Sophie Paczesny, Steven G. E. Marsh, Stephanie L. J. Lee, Stephen R. Spellman, Yung-Tsi Bolon, Katharina Fleischhauer

Summary: This study found that immunopeptidome divergence is a determinant of T-cell alloreactivity and clinical tolerability in single class I HLA-mismatched unrelated donor hematopoietic cell transplantation. Using hierarchical clustering of peptide-binding motifs, the authors classified 68.1% of the HLA-mismatched transplants as matched or mismatched. Mismatched transplants were associated with lower overall survival.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Hematology

Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type

Rohtesh S. Mehta, David Marin, Amin Alousi, Christopher G. Kanakry, Richard E. Champlin, Katayoun Rezvani, Elizabeth J. Shpall, Kristin Page, Shahinaz M. Gadalla, Daniel Weisdorf, Partow Kebriaei

Summary: In adult patients with acute lymphoblastic leukemia, younger haploidentical donors have better overall survival compared to older HLA-matched unrelated donors. Donor age is a prognostic factor for survival in hematopoietic cell transplantation.

BLOOD ADVANCES (2023)

Article Primary Health Care

Prevalence of cancer risk factors among transgender and gender diverse individuals: a cross-sectional analysis using UK primary care data

Jalen Brown, Ruth M. Pfeiffer, Duncan Shrewsbury, Stewart O'Callaghan, Alison M. Berner, Shahinaz M. Gadalla, Meredith S. Shiels, Sarah S. Jackson

Summary: This study found that transgender and gender diverse (TGD) individuals have a higher prevalence of cancer risk factors compared to cisgender individuals. Transmasculine individuals had higher rates of obesity and smoking, while transfeminine individuals had higher rates of dyslipidemia, diabetes, hepatitis C infection, hepatitis B infection, and HIV infection.

BRITISH JOURNAL OF GENERAL PRACTICE (2023)

Article Hematology

The distribution and accumulation of the shortest telomeres in telomere biology disorders

Hannah A. Raj, Tsung-Po Lai, Marena R. Niewisch, Neelam Giri, Youjin Wang, Stephen R. Spellman, Abraham Aviv, Shahinaz M. Gadalla, Sharon A. Savage

Summary: Individuals with telomere biology disorders (TBDs) have significantly shortened telomeres in blood cells, which is associated with increased risk of bone marrow failure and reduced survival. The mean telomere length is estimated to be 5 kilobases, but it is the shortest telomeres that indicate cellular senescence. By using the Telomere Shortest Length Assay (TeSLA), it was found that TBD patients have much shorter mean telomere length and an increased number of telomeres less than 3 kilobases. In addition, TBD patients with severe bone marrow failure and multiple organ manifestations have even shorter telomeres.

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Editorial Material Clinical Neurology

Cancer in myotonic dystrophy: A new discovery in an old disease

Shahinaz M. Gadalla, Mark H. Greene

MUSCLE & NERVE (2023)

Article Multidisciplinary Sciences

Control of protein synthesis through mRNA pseudouridylation by dyskerin

Chiara Pederiva, Davide M. Trevisan, Dimitra Peirasmaki, Shan Chen, Sharon A. Savage, Ola Larsson, Jernej Ule, Laura Baranello, Federico Agostini, Marianne Farnebo

Summary: Posttranscriptional modifications of mRNA, including pseudouridylation, play a crucial role in gene expression regulation. In this study, dyskerin, a pseudouridine synthase, was found to bind to RNA polymerase II and be responsible for pseudouridylation of thousands of mRNAs. Dyskerin-mediated pseudouridylation was shown to interfere with translation and reduction of the modification led to enhanced protein synthesis. Furthermore, dyskeratosis congenita patients with mutations in the dyskerin-encoding gene showed severe reduction in mRNA pseudouridylation.

SCIENCE ADVANCES (2023)

Review Geriatrics & Gerontology

Telomere length and cancer risk: finding Goldilocks

Sharon A. Savage

Summary: Telomere length is crucial in genomic stability and cancer risk, with both too short and too long telomeres associated with increased cancer risks.

BIOGERONTOLOGY (2023)

暂无数据